Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Olympus ( (JP:7733) ) has provided an update.
Olympus Corporation’s board has approved a share repurchase program of up to 46 million common shares, representing about 4.18% of its outstanding stock, for a maximum total of ¥60 billion. The buyback, to be executed between May 13, 2026 and March 31, 2027 via off-auction and open-market purchases on the Tokyo Stock Exchange, aims to strengthen shareholder returns and improve capital efficiency.
The company also plans to cancel all repurchased shares, except for 9 million earmarked for future stock compensation, with the cancellation scheduled for April 30, 2027. This move will reduce the overall share count, potentially enhancing earnings per share and signaling management’s confidence in Olympus’s financial position and commitment to shareholder-friendly capital allocation.
The most recent analyst rating on (JP:7733) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation is a Japan-based manufacturer in the precision instruments and medical technology industry, best known for its endoscopes, imaging systems, and scientific solutions. Listed on the Tokyo Stock Exchange, the company focuses on healthcare-related optical and digital technologies and maintains a significant global presence in medical devices and life-science equipment.
Average Trading Volume: 6,650,062
Technical Sentiment Signal: Sell
Current Market Cap: Yen1730B
Learn more about 7733 stock on TipRanks’ Stock Analysis page.